Philogen SpA

78Q

Company Profile

  • Business description

    Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

  • Contact

    Piazza La Lizza No. 7
    Siena53100
    ITA

    T: +39 0577206941

    https://www.philogen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    183

Stocks News & Analysis

stocks

3 Warren Buffett stocks to avoid today

These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks

Should you invest in small caps?

With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio. 
stocks

Strong second half anticipated for ASX mining play

A more focused business model should benefit the company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,079.2017.700.20%
CAC 407,829.3733.950.44%
DAX 4023,623.0488.210.37%
Dow JONES (US)45,947.32173.96-0.38%
FTSE 1009,244.5230.540.33%
HKSE26,128.20356.48-1.35%
NASDAQ22,384.70113.16-0.50%
Nikkei 22545,354.99399.94-0.87%
NZX 50 Index13,111.7342.06-0.32%
S&P 5006,604.7233.25-0.50%
S&P/ASX 2008,787.7013.200.15%
SSE Composite Index3,828.1125.20-0.65%

Market Movers